Satellite Symposia Schedule

Monday Evening, February 29, 2016, 6:00 – 8:00 PM
MPS I: New horizons and opportunities for change
Supported by PTC Therapeutics, Inc.

Tuesday Morning, March 1, 2016, 6:30 – 7:30 AM
Optimizing Treatment in Morquio A: Capturing multi-domain impact through patient-directed outcomes
Supported by BioMarin Pharmaceutical Inc.

Tuesday Lunchtime, March 1, 2016, 11:45 AM – 12:45 PM
Non-immune hydrops fetalis (NIHF) in lysosomal storage diseases
Supported by Ultragenyx Pharmaceutical Inc.

Tuesday Evening, March 1, 2016, 6:30 – 8:30 PM
The Many Faces of Lysosomal Disease: A Global Perspective
Supported by Amicus Therapeutics

Wednesday Morning, March 2, 2016, 6:30 – 7:30 AM
Discovery and Research Platforms in Rare Disease
Supported by Shire

Wednesday Lunchtime, March 2, 2016, 11:30 AM – 12:45 PM
From diagnosis to treatment: a multidisciplinary approach for the management of Type I Gaucher disease
Supported by Shire International

Wednesday Evening, March 2, 2016, 6:30 – 8:30 PM
How Early is Early? When to Start ERT and Other Considerations for Optimizing Treatment of Fabry Disease
CME Satellite Sponsored by MedIQ. Supported by an educational grant from Sanofi Genzyme

Thursday Morning, March 3, 2016, 6:30 – 7:30 AM
Recognizing the signs of CLN2 disease – emerging evidence for a paradigm shift in CLN2 diagnosis
Supported by BioMarin Pharmaceutical Inc.

Thursday Lunchtime, March 3, 2016, 11:45 AM – 12:45 PM
Patients, exogenous enzymes, and substrate synthesis inhibition: A quarter-century of managing Gaucher disease
Supported by Sanofi Genzyme